HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacotherapy for hyperammonemia.

AbstractINTRODUCTION:
Hepatic encephalopathy (HE) is a serious neuropsychiatric complication that is seen in patients with liver failure. The pathogenesis of HE is not entirely understood, but several hypotheses have emerged and persisted during the years. Despite the many prevalent hypotheses, most of the existing evidence point to ammonia as the main culprit behind primary and secondary symptoms making it the center of potential therapeutic options for the treatment of HE. Most treatments of hyperammonemia target the organs and metabolic processes involved in ammonia detoxification.
AREAS COVERED:
This article provides a review of the current targets of therapy as well as the drugs used for hyperammonemia treatment.
EXPERT OPINION:
Lactulose and rifaximin have a proven role as measures to use for secondary prophylaxis and are the mainstay of current therapy. The use of molecular adsorbent recirculating system in patients with severe HE has been proven to be efficacious, but through mechanisms that appear to be independent of ammonia. The main challenge that faces the further development of treatments for HE is finding appropriate end points, and the next step would be to provide evidence of the effectiveness of established treatments and define the role of emerging new treatments.
AuthorsAnna Hadjihambi, Varun Khetan, Rajiv Jalan
JournalExpert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 15 Issue 12 Pg. 1685-95 (Aug 2014) ISSN: 1744-7666 [Electronic] England
PMID25032885 (Publication Type: Journal Article, Review)
Chemical References
  • Gastrointestinal Agents
  • Rifamycins
  • Lactulose
  • Ammonia
  • Rifaximin
Topics
  • Ammonia (isolation & purification, metabolism)
  • Animals
  • Gastrointestinal Agents (therapeutic use)
  • Hepatic Encephalopathy (complications, drug therapy, metabolism, therapy)
  • Humans
  • Hyperammonemia (complications, drug therapy, metabolism, therapy)
  • Lactulose (therapeutic use)
  • Rifamycins (therapeutic use)
  • Rifaximin
  • Sorption Detoxification

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: